<?xml version="1.0" encoding="UTF-8"?>
<p>Clinical evidence. 
 <italic>Eucalyptus globulus</italic> essential oil preparations have been trialed clinically for respiratory disease (bronchitis, rhinitis), and the following symptoms were evaluated: cough and throat irritation. In an aromatherapy experiment with 48 students diagnosed with allergic rhinitis, eucalyptus reduced coughing, itching sensation in the throat and oral cavity, as well as other symptoms. After four weeks of treatment, the volunteers related a reduction of the discomfort provoked by rhinitis (
 <xref rid="B455" ref-type="bibr">Song and Kim, 2014</xref>). An RCT, involving 152 volunteers with acute non-purulent rhinosinusitis, was carried out with 1,8-cineol, the main compound of eucalyptus essential oil (capsules of 200 mg of oil or placebo, three times daily). After four and seven days, the cineol group presented better symptoms scores than the control group. Moreover, inflammatory processes, such as bronchitis, pharyngitis, tracheitis, conjunctivitis, were less frequent among the verum group (
 <xref rid="B264" ref-type="bibr">Kehrl et al., 2004</xref>). Overall, the clinical evidence is Medium for bronchitis and cough for the essential oil, while for the herbal drug is Low.
</p>
